IMPACT OF CLINICAL PHARMACIST IN THE MONITORING OF DRUG - RELATED PROBLEMS IN PSYCHIATRY PATIENTS AT TERTIARY CARE TEACHING HOSPITAL

Background: Advancement in pharmacotherapy leading the new drug discovery for the clinical problem, as well as it's also exploring the clinical applications and Drug-Related Problem (DRP). DRP is an event or circumstances, which involving drug treatment that interfere or potentially interferes with patient achieving an optimum outcome of medical care. DRP cause significant morbidity and mortality in health care. Method: A prospective, observational study conducted was performed on 120 patients. Patient age more than 18 years of either gender and diagnosed with the psychiatry disorder were enrolled in the study. Result: Total 120 patients were enrolled and five type of DRPs were obtained during the study, ADR 24 (44.4%), drug-drug interaction 6 (11.1%), overdose 12 (22.2%), sub-therapeutic dose 6 (11.1%), failure to receive drug 6 (11.1%). Out of 103 Interventions, 54 (52.4%) suggested recommendation were accepted by the psychiatrists. Conclusion: The overall study suggested that the clinical pharmacist has a huge scope and it is an integral part of the health care team. The clinical pharmacist has greater responsibility in minimizing the DRPs in psychiatric patients and it will help in decreasing chances of comorbidities, length of stay, health care expenditure and all these factors contribute to an improved patient care.